SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402,520 | -34.8% | 116,000 | -12.6% | 0.00% | -50.0% |
| Q2 2023 | $617,055 | +11.8% | 132,700 | +11.0% | 0.00% | 0.0% |
| Q1 2023 | $552,090 | -38.4% | 119,500 | +7.8% | 0.00% | -33.3% |
| Q4 2022 | $896,072 | +27.3% | 110,900 | -12.5% | 0.00% | +50.0% |
| Q3 2022 | $704,000 | -15.5% | 126,758 | -20.8% | 0.00% | 0.0% |
| Q2 2022 | $833,000 | -12.0% | 159,966 | +38.8% | 0.00% | 0.0% |
| Q1 2022 | $947,000 | +13.4% | 115,230 | +105.3% | 0.00% | 0.0% |
| Q4 2021 | $835,000 | -21.2% | 56,130 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,060,000 | +1.6% | 56,130 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,043,000 | +25.8% | 56,130 | +54.1% | 0.00% | 0.0% |
| Q1 2021 | $829,000 | +4.8% | 36,430 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $791,000 | +189.7% | 36,430 | +34.3% | 0.00% | +100.0% |
| Q3 2020 | $273,000 | +110.0% | 27,130 | +61.5% | 0.00% | – |
| Q2 2020 | $130,000 | -24.0% | 16,800 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $171,000 | -4.5% | 16,800 | +3.1% | 0.00% | – |
| Q4 2019 | $179,000 | +20.9% | 16,300 | 0.0% | 0.00% | – |
| Q3 2019 | $148,000 | – | 16,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |